Oral microbiota and cancer

Jukka H Meurman, Jukka H Meurman

Abstract

Inflammation caused by infections may be the most important preventable cause of cancer in general. However, in the oral cavity the role of microbiota in carcinogenesis is not known. Microbial populations on mouth mucosa differ between healthy and malignant sites and certain oral bacterial species have been linked with malignancies but the evidence is still weak in this respect. Nevertheless, oral microorganisms inevitably up-regulate cytokines and other inflammatory mediators that affect the complex metabolic pathways and may thus be involved in carcinogenesis. Poor oral health associates statistically with prevalence of many types of cancer, such as pancreatic and gastrointestinal cancer. Furthermore, several oral micro-organisms are capable of converting alcohol to carcinogenic acetaldehyde which also may partly explain the known association between heavy drinking, smoking, poor oral health and the prevalence of oral and upper gastrointestinal cancer. A different problem is the cancer treatment-caused alterations in oral microbiota which may lead to the emergence of potential pathogens and subsequent other systemic health problems to the patients. Hence clinical guidelines and recommendations have been presented to control oral microbiota in patients with malignant disease, but also in this area the scientific evidence is weak. More controlled studies are needed for further conclusion.

Keywords: cancer; carcinogenesis; oral bacteria; oral microbiota.

References

    1. Herrera V, Parsonnet J. Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect. 2009;15:971–6.
    1. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007;449:804–10.
    1. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480–4.
    1. Preza D, Olsen I, Willumsen T, Grinde B, Paster BJ. Diversity and site-specificity of the oral microflora in the elderly. Eur J Clin Microbiol Infect Dis. 2009;28:1033–40.
    1. Fischetti VA. Novel method to control pathogenic bacteria on human mucous membranes. Ann NY Acad Sci. 2003;987:207–14.
    1. Tachibana M, Yoshida A, Ansai T, Takata Y, Akifusa S, Fukuhara M, et al. Prevalence of periodontopathic bacteria on the tongue dorsum of elderly people. Gerodontology. 2006;23:123–6.
    1. Brook I. The role of bacterial interference in otitis, sinusitis and tonsillitis. Otolaryngol Head Neck Surg. 2005;33:139–46.
    1. Gendron R, Grenier D, Maheu-Robert L. The oral cavity as a reservoir of bacterial pathogens for focal infections. Microbes Infect. 2000;2:897–906.
    1. Desai HG, Gill HH, Shankaran K, Mehta PR, Prabhu SR. Dental plaque: a permanent reservoir of Helicobacter pylori? Scand J Gastroenterol. 1991;26:1205–8.
    1. Komiyama K, Tynan JJ, Habbick BF, Duncan DE, Liepert DJ. Pseudomonas aeruginosa in the oral cavity and sputum of patients with cystic fibrosis. Oral Surg Oral Med Oral Pathol. 1985;59:590–4.
    1. Scannapieco FA. Position paper of The American Academy of Periodontology: periodontal disease as a potential risk factor for systemic diseases. J Periodontol. 1998;69:841–50.
    1. Slots J, Rams TE. New views on periodontal microbiota in special patient categories. J Clin Periodontol. 1991;18:411–20.
    1. Meurman JH, Uittamo J. Oral micro-organisms in the etiology of cancer. Acta Odontol Scand. 2008;66:321–6.
    1. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–7.
    1. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436–4.
    1. Fantini MC, Pallone F. Cytokines: from gut inflammation to colorectal cancer. Curr Drug Targets. 2008;9:375–80.
    1. Allavena P, Garlanda C, Borrello MG, Sica A, Mantovani A. Pathways connecting inflammation and cancer. Curr Opin Genet Dev. 2008;18:3–10.
    1. Parsonnet J. New York: Oxford University Press; 1999. Microbes and malignancy; pp. 3–15.
    1. Butel JS. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis. 2000;21:405–26.
    1. Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med. 2000;248:171–83.
    1. Megraud F, Brassens-Rabbe MP, Denis F, Belbouri A, Hoa DQ. Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol. 1989;27:1870–3.
    1. Martin D, Gutkind JS. Human tumor-associated viruses and new insights into the molecular mechanisms of cancer. Oncogene. 2008;27:31–42.
    1. Grinde B, Olsen I. The role of viruses in oral disease. J Oral Microbiol. 2010;2:2127. doi: 10.3402/jom.v.2i0.2127.
    1. Watabe K, Nishi M, Miyake H, Hirata K. Lifestyle and gastric cancer: a case-control study. Oncol Rep. 1998;5:1191–4.
    1. Demirer T, Icli F, Uzunalimoglu O, Kucuk O. Diet and stomach cancer incidence. A case-control study in Turkey. Cancer. 1990;65:2344–8.
    1. Wolff G, Lauter J. On epidemiology of gastric cancer (author's transl) Arch Geschwulstforsch. 1976;46:1–14.
    1. Abnet CC, Qiao YL, Mark SD, Dong ZW, Taylor PR, Dawsey SM. Prospective study of tooth loss and incident esophageal and gastric cancers in China. Cancer Causes Control. 2001;12:847–54.
    1. Hujoel PP, Drangsholt M, Spiekerman C, Weiss NS. An exploration of the periodontitis–cancer association. Ann Epidemiol. 2003;13:312–6.
    1. Stolzenberg-Solomon RZ, Dodd KW, Blaser MJ, Virtamo J, Taylor PR, Albanes D. Tooth loss, pancreatic cancer, and Helicobacter pylori . Am J Clin Nutr. 2003;78:176–81.
    1. Michaud DS, Joshipura K, Giovannucci E, Fuchs CS. A prospective study of periodontal disease and pancreatic cancer in US male health professionals. J Natl Cancer Inst. 2007;99:171–5.
    1. Lin CY, Chao PC, Hong GJ, Tsai YT, Lee CY, Tsai CS. Infective endocarditis from Streptococcus viridans associated with colonic carcinoma: a case report. J Card Surg. 2008;23:263–5.
    1. Siegert CE, Overbosch D. Carcinoma of the colon presenting as Streptococcus sanguis bacteremia. Am J Gastroenterol. 1995;90:1528–9.
    1. Michaud DS, Liu Y, Meyer M, Giovannucci E, Joshipura K. Periodontal disease, tooth loss, and cancer risk in male health professionals: a prospective cohort study. Lancet Oncol. 2008;9:550–8.
    1. Tezal M, Sullivan MA, Reid ME, Marshall JR, Hyland A, Loree T, et al. Chronic periodontitis and the risk of tongue cancer. Arch Otolaryngol Head Neck Surg. 2007;133:450–4.
    1. Tezal M, Sullivan MA, Hyland A, Marshall JR, Stoler D, Reid ME, et al. Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2009;18:2406–12.
    1. Abnet CC, Kamangar F, Islami F, Nasrollahzadeh D, Brennan P, Aghcheli K, et al. Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2008;17:3062–8.
    1. Holmes L, desVignes-Kendrik M, Slomka J, Mahabir S, Beeravolu S, Emani SR. Is dental care utilization associated with oral cavity cancer in a large sample of community-based United States residents? Community Dent Oral Epidemiol. 2009;37:134–42.
    1. Rautemaa R, Hietanen J, Niissalo S, Pirinen S, Perheentupa J. Oral and oesophageal squamous cell carcinoma – a complication or component of autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy (APECED, APS-I) Oral Oncol. 2007;43:607–13.
    1. Rosa DD, Pasqualotto AC, Denning DW. Chronic mucocutaneous candidiasis and oesophageal cancer. Med Mycol. 2008;46:85–91.
    1. Söder B, Klinge B, Söder P-Ö. Periodontitis and premature death: a 16-year longitudinal study in a Swedish urban population. J Periodontal Res. 2007;42:361–6.
    1. Hooper SJ, Wilson MJ, Crean SJ. Exploring the link between microorganisms and oral cancer: a systematic review of the literature. Head Neck. 2009;31:1228–39.
    1. Migliorati CA. Periodontal disease and cancer. Periodontal diseases and cancer. Lancet Oncol. 2008;9:510–2.
    1. Meyer MS, Joshipura K, Giovannucci E, Michaud DS. A review of the relationship between tooth loss, periodontal disease, and cancer. Cancer Causes Control. 2008;19:895–907.
    1. Meurman JH. Infectious and dietary risk factors of oral cancer. Oral Oncol. 2010;46:411–3.
    1. Meurman JH, Sanz M, Janket SJ. Oral health, atherosclerosis, and cardiovascular disease. Crit Rev Oral Biol Med. 2004;15:403–13.
    1. Lax AJ, Thomas W. How bacteria could cause cancer: one step at a time. Trends Microbiol. 2002;10:293–9.
    1. Katz J, Wallet S, Cha S. Periodontal disease and the oral-systemic connection: “Is it all the RAGE?”. Quintessence Int. 2010;41:229–37.
    1. Lalla E, Lamster IB, Stern DM, Schmidt AM. Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities. Ann Periodontol. 2001;6:113–8.
    1. Janket SJ, Jones JA, Meurman JH, Baird AE, Van Dyke TE. Oral infection, hyperglycemia, and endothelial dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:173–9.
    1. Sheu BC, Chang WC, Cheng CY, Lin HH, Chang DY, Huang SC. Cytokine regulation networks in the cancer microenvironment. Front Biosci. 2008;13:6255–68.
    1. Bloching M, Reich W, Schubert J, Grummt T, Sandner A. The influence of oral hygiene on salivary quality in the Ames Test, as a marker for genotoxic effects. Oral Oncol. 2007;43:933–9.
    1. Jeng JH, Chang MC, Hahn LJ. Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol. 2001;37:477–92.
    1. Homann N, Tillonen J, Salaspuro M. Microbially produced acetaldehyde from ethanol may increase the risk of colon cancer via folate deficiency. Int J Cancer. 2000;86:169–73.
    1. Homann N, Tillonen J, Meurman JH, Rintamäki H, Lindqvist C, Rautio M, et al. Increased salivary acetaldehyde levels in heavy drinkers and smokers: a microbiological approach to oral cavity cancer. Carcinogenesis. 2000;21:663–8.
    1. Kurkivuori J, Salaspuro V, Kaihovaara P, Kari K, Rautemaa R, Grönroos L, et al. Acetaldehyde production from ethanol by oral streptococci. Oral Oncol. 2007;43:181–6.
    1. Uittamo J, Siikala E, Kaihovaara P, Salaspuro M, Rautemaa R. Chronic candidosis and oral cancer in APECED-patients: production of carcinogenic acetaldehyde from glucose and ethanol by Candida albicans . Int J Cancer. 2009;124:754–6.
    1. Nieminen MT, Uittamo J, Salaspuro M, Rautemaa R. Acetaldehyde production from ethanol and glucose by non-Candida albicans yeasts in vitro. Oral Oncol. 2009;45:e245–8.
    1. Marichalar-Mendia X, Rodriguez-Tojo MJ, Acha-Sagredo A, Rey-Barja N, Aguirre-Urizar JM. Oral cancer and polymorphism of ethanol metabolising genes. Oral Oncol. 2010;46:9–13.
    1. Cancela Mde C, Ramadas K, Fayette JM, Thomas G, Muwonge R, Chapuis F, et al. Alcohol intake and oral cavity cancer risk among men in a prospective study in Kerala, India. Community Dent Oral Epidemiol. 2009;37:342–9.
    1. Morse DE, Psoter WJ, Cleveland D, Cohen D, Mohit-Tabatabai M, Kosis DL, et al. Smoking and drinking in relation to oral cancer and oral epithelial dysplasia. Cancer Causes Control. 2007;18:919–29.
    1. Salaspuro V, Salaspuro M. Synergistic effect of alcohol drinking and smoking on in vivo acetaldehyde concentration in saliva. Int J Cancer. 2004;111:480–3.
    1. Narikiyo M, Tanabe C, Yamada Y, Igaki H, Tachimori Y, Kato H, et al. Frequent and preferential infection of Treponema denticola, Streptococcus mitis, and Streptococcus anginosus in esophageal cancers. Cancer Sci. 2004;95:569–74.
    1. Shiga K, Tateda M, Saijo S, Hori T, Sato I, Tateno H, et al. Presence of streptococcus infection in extra-oropharyngeal head and neck squamous cell carcinoma and its implication in carcinogenesis. Oncol Rep. 2001;8:245–8.
    1. Sasaki M, Yamaura C, Ohara-Nemoto Y, Tajika S, Kodama Y, Ohya T, et al. Streptococcus anginosus infection in oral cancer and its infection route. Oral Dis. 2005;11:151–6.
    1. Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR, Goodson JM. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Translational Med. 2009;3:27.
    1. Liao PH, Chang YC, Huang MF, Tai KW, Chou MY. Mutation of p53 gene codon 63 in saliva as a molecular marker for oral squamous cell carcinomas. Oral Oncol. 2000;36:272–6.
    1. Kim MM, Clinger JD, Masayesva BG, Ha PK, Zahurak ML, Westra WH, et al. Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions. Clin Cancer Res. 2004;10:8512–5.
    1. Vieira J, O'Hearn P, Kimball L, Chandran B, Corey L. Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus. J Virol. 2001;75:1378–86.
    1. Maticic M, Poljak M, Kramar B, Tomazic J, Vidmar L, Zakotnik B, et al. Proviral HIV-1 DNA in gingival crevicular fluid of HIV-1-infected patients in various stages of HIV disease. J Dent Res. 2000;79:1496–501.
    1. Seoane Lestón J, Diz Dios P. Diagnostic clinical aids in oral cancer. Oral Oncol. 2010;46:418–22.
    1. Wu JY, Yi C, Chung HR, Wang DJ, Chang WC, Lee SY, et al. Potential biomarkers in saliva for oral squamous cell carcinoma. Oral Oncol. 2010;46:226–31.
    1. Keijser BJ, Zaura E, Huse SM, van der Vossen JM, Schuren FH, Montijn RC, et al. Pyrosequencing analysis of the oral microflora of healthy adults. J Dent Res. 2008;87:1016–20.
    1. Kuo WP. Overview of bioinformatics and its application to oral genomics. Adv Dent Res. 2003;17:89–94.
    1. Kuo WP, Mendez E, Chen C, Whipple ME, Farell G, Agoff N, et al. Functional relationships between gene pairs in oral squamous cell carcinoma. AMIA Annu Symp Proc. 2003:371–5.
    1. Fábián TK, Fejérdy P, Csermely P. Salivary genomics, transcriptomics and proteomics: the emerging concept of the oral ecosystem and their use in the early diagnosis of cancer and other diseases. Curr Genomics. 2008;9:11–21.
    1. Rautemaa R, Rusanen P, Richardson M, Meurman JH. Optimal sampling site for mucosal candidosis in oral cancer patients is the labial sulcus. J Med Microbiol. 2006;55:1447–51.
    1. Rusanen P, Siikala E, Uittamo J, Richardson M, Rautemaa R. A novel method for sampling the microbiota from the oral mucosa. Clin Oral Investig. 2009;13:243–6.
    1. Sixou JL, De Medeiros-Batista O, Gandemer V, Bonnaure-Mallet M. The effect of chemotherapy on the supragingival plaque of pediatric cancer patients. Oral Oncol. 1998;34:476–83.
    1. Almståhl A, Wikström M, Fagerberg-Mohlin B. Microflora in oral ecosystems in subjects with radiation-induced hyposalivation. Oral Dis. 2008;14:541–9.
    1. Tong HC, Gao XJ, Dong XZ. Non-mutants streptococci in patients receiving radiotherapy in the head and neck area. Caries Res. 2003;37:261–6.
    1. Leung WK, Jin LJ, Samaranayake LP, Chiu GK. Subgingival microbiota of shallow periodontal pockets in individuals after head and neck irradiation. Oral Microbiol Immunol. 1998;13:1–10.
    1. Lucas VS, Beighton D, Roberts GJ, Challacombe SJ. Changes in the oral streptococcal flora of children undergoing allogeneic bone marrow transplantation. J Infect. 1997;35:135–41.
    1. Dens FL, Boute P, Vinckier F, Declerck D. Salivary caries risk factors in long-term event-free survivors of pediatric malignant diseases. J Clin Pediatr Dent. 1996;20:241–5.
    1. Peterson DE, Minah GE, Reynolds MA, Weikel DS, Overholser CD, DePaola LG, et al. Effect of granulocytopenia on oral microbial relationships in patients with acute leukemia. Oral Surg Oral Med Oral Pathol. 1990;70:720–3.
    1. Pompei R, Ingianni A, Cagetti MG, Rizzo A, Cotti S. Evaluation of the opportunistic microbial flora and of some antimicrobial factors in the oral cavity of leukaemic patients. Microbios. 1993;75:149–57.
    1. Reynolds MA, Minah GE, Peterson DE, Weikel DS, Williams LT, Overholser CD, et al. Periodontal disease and oral microbial successions during myelosuppressive cancer chemotherapy. J Clin Periodontol. 1989;16:185–9.
    1. Sixou JL, Aubry-Leuliette A, De Medeiros-Battista O, Lejeune S, Jolivet-Gougeon A, Solhi-Pinsard H, et al. Capnocytophaga in the dental plaque of immunocompromised children with cancer. Int J Paediatr Dent. 2006;16:75–80.
    1. Meurman JH, Grönroos L. Oral and dental health care of oral cancer patients: hyposalivation, caries and infections. Oral Oncol. 2010;46:464–7.
    1. Meurman JH, Pyrhönen S, Teerenhovi L, Lindqvist C. Oral sources of septicaemia in patients with malignancies. Oral Oncol. 1997;33:389–97.
    1. Tomás I, Alvarez M, Limeres J, Tomás M, Medina J, Otero JL, et al. Effect of a chlorhexidine mouthwash on the risk of postextraction bacteremia. Infect Control Hosp Epidemiol. 2007;28:577–82.
    1. Sorensen JB, Skovsgaard T, Bork E, Damstrup L, Ingeberg S. Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer. 2008;112:1600–6.
    1. Madan PD, Sequeira PS, Shenoy K, Shetty J. The effect of three mouthwashes on radiation-induced oral mucositis in patients with head and neck malignancies: a randomized control trial. J Cancer Res Ther. 2008;4:3–8.
    1. Wahlin YB. Effects of chlorhexidine mouthrinse on oral health in patients with acute leukemia. Oral Surg Oral Med Oral Pathol. 1989;68:279–87.
    1. Antunes HS, Ferreira EM, de Faria LM, Schirmer M, Rodrigues PC, Small IA, et al. Streptococcal bacteraemia in patients submitted to hematopoietic stem cell transplantation: the role of tooth brushing and use of chlorhexidine. Med Oral Patol Oral Cir Bucal. 2010;15:e303–9.
    1. Langslet A, Olsen I, Lie SO, Lokken P. Chlorhexidine treatment of oral candidiasis in seriously diseased children. Acta Paediatr Scand. 1974;63:809–11.
    1. Laine P, Meurman JH, Murtomaa H, Lindqvist C, Torkko H, Pyrhönen S, et al. One-year trial of the effect of rinsing with an amine fluoride–stannous–fluoride-containing mouthwash on gingival index scores and salivary microbial counts in lymphoma patients receiving cytostatic drugs. J Clin Periodontol. 1993;20:628–34.
    1. Meurman JH, Laine P, Murtomaa H, Lindqvist C, Torkko H, Teerenhovi L, et al. Effect of antiseptic mouthwashes on some clinical and microbiological findings in the mouths of lymphoma patients receiving cytostatic drugs. J Clin Periodontol. 1991;18:587–91.
    1. Stokman MA, Spijkervet FK, Boezen HM, Schouten JP, Roodenburg JL, de Vries EG. Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses. J Dent Res. 2006;85:690–700.
    1. Worthington HV, Clarkson JE, Eden OB. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev. 2007;4:CD000978.
    1. Sjögren P, Nilsson E, Forsell M, Johansson O, Hoogstraate J. A systematic review of the preventive effect of oral hygiene on pneumonia and respiratory tract infection in elderly people in hospitals and nursing homes: effect estimates and methodological quality of randomized controlled trials. J Am Geriatr Soc. 2008;56:2124–30.
    1. Akutsu Y, Matsubara H, Okazumi S, Shimada H, Shuto K, Shiratori T, et al. Impact of preoperative dental plaque culture for predicting postoperative pneumonia in esophageal cancer patients. Dig Surg. 2008;25:93–7.
    1. Chandu A, Stulner C, Bridgeman AM, Smith AC. Maintenance of mouth hygiene in patients with oral cancer in the immediate post-operative period. Aust Dent J. 2002;47:170–3.
    1. Salaspuro V, Hietala J, Kaihovaara P, Pihlajarinne L, Marvola M, Salaspuro M. Removal of acetaldehyde from saliva by a slow-release buccal tablet of L-cysteine. Int J Cancer. 2002;97:361–4.
    1. Salaspuro V. Pharmacological treatments and strategies for reducing oral and intestinal acetaldehyde. Novartis Found Symp. 2007;285:145–53. (Discussion 153–7, 198–9)
    1. De Vries N, De Flora S. N-acetyl-L-cysteine. J Cell Biochem. 1993;17:270–7.
    1. Van Schooten FJ, Besaratinia A, De Flora S, D'Agostini F, Izzotti A, Camoirano A, et al. Effects of oral administration of N-acetyl-L-cysteine: a multi-biomarker study in smokers. Cancer Epidemiol Biomarkers Prev. 2002;11:167–75.
    1. Salaspuro VJ, Hietala JM, Marvola ML, Salaspuro MP. Eliminating carcinogenic acetaldehyde by cysteine from saliva during smoking. Cancer Epidemiol Biomarkers Prev. 2006;15:146–9.
    1. Morini M, Cai T, Aluigi MG, Noonan DM, Masiello L, De Flora S, et al. The role of the thiol N-acetylcysteine in the prevention of tumor invasion and angiogenesis. Int J Biol Markers. 1999;14:268–71.
    1. King K, Jones DH, Daltrey DC, Cunliffe WJ. A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population. Br J Dermatol. 1982;107:583–90.
    1. Krinsky NI. Antioxidant functions of carotenoids. Free Radic Biol Med. 1989;7:617–35.
    1. Tengerdy RP. The role of vitamin E in immune response and disease resistance. Ann NY Acad Sci. 1990;587:24–33.
    1. Liede K, Hietanen J, Saxen L, Haukka J, Timonen T, Häyrinen-Immonen R, et al. Long-term supplementation with alpha-tocopherol and beta-carotene and prevalence of oral mucosal lesions in smokers. Oral Dis. 1998;4:78–83.
    1. Liede KE, Alfthan G, Hietanen JH, Haukka JK, Saxen LM, Heinonen OP. Beta-carotene concentration in buccal mucosal cells with and without dysplastic oral leukoplakia after long-term beta-carotene supplementation in male smokers. Eur J Clin Nutr. 1998;52:872–6.
    1. Lai PK, Roy J. Antimicrobial and chemopreventive properties of herbs and spices. Curr Med Chem. 2004;11:1451–60.
    1. Taylor PW, Hamilton-Miller JM, Stapleton PD. Antimicrobial properties of green tea catechins. Food Sci Technol Bull. 2005;2:71–81.
    1. Miller EG, Peacock JJ, Bourland TC, Taylor SE, Wright JM, Patil BS, et al. Inhibition of oral carcinogenesis by citrus flavonoids. Nutr Cancer. 2008;60:69–74.
    1. Ide R, Fujino Y, Hoshiyama Y, Mizoue T, Kubo T, Pham TM, et al. A prospective study of green tea consumption and oral cancer incidence in Japan. Ann Epidemiol. 2007;17:821–6.
    1. Meurman JH, Stamatova I. Probiotics: contributions to oral health. Oral Dis. 2007;13:443–51.
    1. Stamatova I, Meurman JH. Probiotics: health benefits in the mouth. Am J Dent. 2009;22:329–38.
    1. Kumar M, Kumar A, Nagpal R, Mohania D, Behare P, Verma V, et al. Cancer-preventing attributes of probiotics: an update. Int J Food Sci Nutr. 2010;61:473–96.
    1. Maria-Aggeliki KS, Nikolaos KL, George KM, Vassilis KE. The potential clinical impact of probiotic treatment for the prevention and/or anti-inflammatory therapeutic effect against radiation induced intestinal mucositis. A review. Recent Pat Inflamm Allergy Drug Discov. 2009;3:195–200.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir